R&D center as one of the core department of GreenPine, is responsible for the research of all the products, including clinical trial, pharmacology and toxicology experiment, as well as related research of pre-market product. At the same time, R&D center is also responsible for the cooperation with universities and academic institutions. Since established in 2002, GreenPine has achieved more than 30 IDLs of API and finish products. There are more than a dozen of products under evaluation currently. So far, Greenpine has been authorized one patent. Two patents were public to in 2011.Three patents were submitted in 2012.
R&D center is one of the unique components of Greenpine. Additionally, intellectual property rights guarantee Greenpine not disciplined by others. R&D will play more important role in the future.